The Paradigm Shift from Traditional Scientific Platforms to Integrated Communications Plans

In the rapidly evolving biopharma landscape, the approach to scientific communications is undergoing a significant transformation. The shift from traditional scientific platforms to integrated communications plans (ICPs) is becoming increasingly crucial for ensuring cohesive and impactful messaging. This article delves into the components, implementation, and benefits of an ICP tailored for the biopharma industry, addressing the challenges of fragmented messaging and the need for a unified communication strategy...
Read More

Top Stories

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Health Literacy Month

Celebrating Health Literacy Month 2024:

October is Health Literacy Month, a reminder of the...

World Patient Safety Day September 17, 2021 – Safe Maternal and Newborn Care

This World Patient Safety Day, let's make maternal and newborn care a global health priority...
Strategic publication planning: A handy infographic for medical affairs

Strategic Publication Planning: Infographic for Medical Affairs

Here's a quick and easy-to-follow guide on for medical affairs teams on the what, how...
Pexels Alexander Suhorucov

Plain Language Summary Development in Japan: Current State and Challenges

This page contains supplementary information to support a poster presented at the Virtual 17th Annual...
Publication planning training

Publication Planning Training for Regional Medical Affairs Team

How a global pharma company overcame challenges of integration with regional teams in terms of...
FDA social media usage guidelines

US FDA (Food And Drug Administration) Social Medial Usage Guidelines: Compliance for Pharma Companies

This poster presents results of an analysis of trends in adherence of pharmaceutical companies to...

Learn more ABOUT our company.